| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MIRATI THERAPEUTICS INC COM | 1,404,055 | 30,047,000 | 10.48% | ||
| 2 | AMICUS THERAPEUTICS INC | 3,424,104 | 28,934,000 | 10.09% | ||
| 3 | BIOMARIN | 277,272 | 22,869,000 | 7.98% | ||
| 4 | SAREPTA THERAPEUTICS INC | 1,155,000 | 22,546,000 | 7.87% | ||
| 5 | GILEAD SCIENCES INC | 175,400 | 16,112,000 | 5.62% | ||
| 6 | NEUROCRINE BIOSCIE COM USD0.001 | 405,320 | 16,030,000 | 5.59% | ||
| 7 | Lion Biotechnologies | 3,125,198 | 15,876,000 | 5.54% | ||
| 8 | CELATOR PHARMACEUTICALS INC | 1,416,257 | 15,621,000 | 5.45% | ||
| 9 | MEDIVATION INC | 270,665 | 12,445,000 | 4.34% | ||
| 10 | BRISTOL MYERS SQUIBB CO | 175,000 | 11,179,000 | 3.90% | ||
| 11 | AGENUS INC | 2,400,868 | 9,988,000 | 3.48% | ||
| 12 | Anacor Pharmaceuticals Inc | 166,700 | 8,910,000 | 3.11% | ||
| 13 | NEURODERM LTD | 537,477 | 7,589,000 | 2.65% | ||
| 14 | VANDA PHARMACEUTICALS INC COM | 854,579 | 7,144,000 | 2.49% | ||
| 15 | TESARO INC | 150,000 | 6,605,000 | 2.30% | ||
| 16 | SORRENTO THERAPEUTICS INC COM NEW | 1,145,779 | 6,164,000 | 2.15% | ||
| 17 | ONCOTHYREON INC COM N/C EFF 6/ | 4,069,072 | 5,168,000 | 1.80% | ||
| 18 | TELIGENT INC NEW | 925,000 | 4,533,000 | 1.58% | ||
| 19 | LA JOLLA PHARMACEUTICAL CO | 211,672 | 4,426,000 | 1.54% | ||
| 20 | FORTRESS BIOTECH INC | 1,337,869 | 4,147,000 | 1.45% | ||
| 21 | PERNIX THERAPEUTICS HLDGS IN | 3,889,900 | 4,084,000 | 1.42% | ||
| 22 | VERACYTE INC | 730,514 | 3,945,000 | 1.38% | ||
| 23 | DERMIRA INC | 175,000 | 3,619,000 | 1.26% | ||
| 24 | GLOBAL BLOOD THERAPEUTICS IN COM | 208,086 | 3,300,000 | 1.15% | ||
| 25 | IMMUNOMEDICS INC | 1,050,457 | 2,626,000 | 0.92% | ||
| 26 | TRILLIUM THERAPEUTICS INC | 228,697 | 2,115,000 | 0.74% | ||
| 27 | SAREPTA THERAPEUTICS INC | 307,500 | 2,006,000 | 0.70% | Call | |
| 28 | VERICEL CORP | 275,000 | 1,612,000 | 0.56% | ||
| 29 | Nantkwest Inc | 194,912 | 1,602,000 | 0.56% | ||
| 30 | Egalet Corp | 233,334 | 1,601,000 | 0.56% | ||
| 31 | AEGERION PHARMACEUTICALS INC | 306,800 | 1,135,000 | 0.40% | ||
| 32 | CORVUS PHARMACEUTICALS INC COM | 74,800 | 1,085,000 | 0.38% | ||
| 33 | CELLECTIS S A | 25,000 | 688,000 | 0.24% | ||
| 34 | SPDR S&P BIOTECH ETF | 750,000 | 670,000 | 0.23% | Put | |
| 35 | Catalyst Biosciences | 71,500 | 120,000 | 0.04% | ||
| 36 | INTREXON CORP | 200,000 | 60,000 | 0.02% | Call | |
| 37 | ISHARES TR | 250,000 | 51,000 | 0.02% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-102561, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
